Research output per year
Research output per year
Personal profile
Research interests
I am interested in the role of fungal allergens in allergic rhinitis and asthma, particualrly with respect to the production of nasal cytokines. I am also interested in new treatment modalities for chronic urticaria as well as other atopic diseases.
Clinical interests
Asthma, urticaria, hives, children with asthma, infectious diseases, allergies, allergic diseases, immunological diseases, allergic reactivity, allergic conjunctivitis, articulation of asthma, eosinophilia, usage of antibodies, immunochemistry, lymphocyte activation, development of immunities, clinical immunology, chronic fatigue syndrome, fungal allergies, environmental control for allergies
Fingerprint
Dive into the research topics where James Wedner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)
Wedner, H. J., Fujisawa, T., Guilbert, T. W., Ikeda, M., Mehta, V., Tam, J. S., Lukka, P. B., Asimus, S., Durżyński, T., Johnston, J., White, W. I., Shah, M., Werkström, V. & Jison, M. L., Mar 2024, In: Pediatric Allergy and Immunology. 35, 3, e14092.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity
Zimmerman, O., Altman Doss, A. M., Ying, B., Liang, C. Y., Mackin, S. R., Davis-Adams, H. G., Adams, L. J., VanBlargan, L. A., Chen, R. E., Scheaffer, S. M., Desai, P., Raju, S., Mantia, T. L., O’Shaughnessy, C. C., Monroy, J. M., James Wedner, H., Rigell, C. J., Kau, A. L., Dy, T. B. & Ren, Z. & 7 others, , Feb 8 2024, In: JCI Insight. 9, 3, e176359.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study
SPRING Investigators, Maurer, M., Lumry, W. R., Li, H. H., Aygören-Pürsün, E., Busse, P. J., Jacobs, J., Nurse, C., Ahmed, M. A., Watt, M., Yu, M., Yang, W. H., Aygören-Pürsün, E., Martinez-Saguer, I., Maurer, M., Farkas, H., Perosa, M., Bernstein, J., Busse, P. & Jacobs, J. S. & 6 others, , Jan 2024, In: Journal of Allergy and Clinical Immunology: In Practice. 12, 1, p. 201-211.e6Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial
APeX-2 investigators, Mar 2024, In: Journal of Allergy and Clinical Immunology: In Practice. 12, 3, p. 733-743.e10Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Insights into the pathogenesis of hereditary angioedema using genetic sequencing and recombinant protein expression analyses
Ren, Z., Zhao, S., Li, T., Wedner, H. J. & Atkinson, J. P., Apr 2023, In: Journal of Allergy and Clinical Immunology. 151, 4, p. 1040-1049.e5Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations